Similar to our previous work, increased levels of antigen-specific CD8+ T-cells induced by a DC-SIGN-targeting OVA-LeB vaccine did not enhance the anti-tumor effect; only in combination with Treg depletion was an anti-tumor effect observed [13]. This evidence concerns the gene CD209 and neoplasm.